To access this content, you must purchase a Premium membership, or log in if you are a member.
SHINE receives $32 million to produce medical diagnostics ingredient
Building a Secure Future in Medicine: Chrysalis, SHINE's innovative facility under construction in Janesville, Wisconsin. Chrysalis will produce Mo-99, a critical medical isotope, for the U.S., ensuring a reliable supply for millions of patients.
Janesville-based SHINE Technologies has received $32 million from the federal Department of Energy to support its effort to produce a key ingredient used in medical diagnostics.